The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases
Abstract
Human papillomavirus (HPV) causes greater than 5% of cancers worldwide, including all cervical cancers and an alarmingly increasing proportion of oropharyngeal cancers (OPCs). Despite markedly reduced cervical cancer incidence in industrialized nations with organized screening programs, cervical cancer remains the second most common cause of death from cancer in women worldwide, as developing countries lack resources for universal, high‐quality screening. In the United States, HPV‐related OPC is only 1 of 5 cancers with a rising incidence since 1975 and now has taken over the cervix as the most common site of HPV‐related cancer. Similar trends follow throughout North America and Europe. The need for early detection and prevention is paramount. Despite the common etiologic role of HPV in the development of cervical cancer and HPV‐associated OPC, great disparity exists between incidence, screening modalities (or lack thereof), treatment, and prevention in these 2 very distinct cohorts. These differences in cervical cancer and HPV‐associated OPC and their impact are discussed here. Cancer 2017;123:2219–2229. © 2017 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Ferris, R. L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Harrington, K., Kasper, S., Vokes, E. E., Even, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602252 · Cited by 5,101
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4596 · Cited by 3,638
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
Gillison, M. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.709 · Cited by 3,101
The National Comprehensive Cancer Network (NCCN).
Wood, E. H. (2004) · Journal of the Medical Library Association JMLA · Cited by 2,845
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Global Burden of Human Papillomavirus and Related Diseases
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.055 · Cited by 1,642
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30143-7 · Cited by 1,635
The Biology and Life-Cycle of Human Papillomaviruses
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.083 · Cited by 1,528
Cited by
Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma
Barsouk, A., Aluru, J. S., Rawla, P., Saginala, K., & Barsouk, A. (2023) · Medical Sciences · doi:10.3390/medsci11020042 · Cited by 751
Therapeutic cancer vaccines: Advancements, challenges, and prospects
Fan, T., Zhang, M., Yang, J., Zhu, Z., Cao, W., & Dong, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01674-3 · Cited by 597
“…the testis and melanoma, respectively, whereas human papillomavirus (HPV)-associated cervical and oropharyngeal cancers have high expression of the E6 and E7 proteins of high-risk HPV. 17,18 Therefore, the shared TAAs in patients with cancer make it a promising off-the-shelf immunotherapy option.”
BackgroundThe HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets
Hoppe-Seyler, K., Bossler, F., Braun, J. A., Herrmann, A. L., & Hoppe-Seyler, F. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2017.07.007 · Cited by 457
Graham, S. V. (2017) · Clinical Science · doi:10.1042/cs20160786 · Cited by 456
Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden
Hashim, D., Genden, E., Posner, M., Hashibe, M., & Boffetta, P. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz084 · Cited by 265
Chrysostomou, A. C., Stylianou, D. C., Constantinidou, A., & Kostrikis, L. G. (2018) · Viruses · doi:10.3390/v10120729 · Cited by 258
Ni, H., Zhang, H., Li, L., Huang, H., Guo, H., Zhang, L., Li, C., Xu, J.-X., Nie, C.-P., Li, K., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005151 · Cited by 85
Kassirian, S., Dzioba, A., Hamel, S., Patel, K., Sahovaler, A., Palma, D. A., Read, N., Venkatesan, V., Nichols, A. C., Yoo, J., et al. (2020) · Current Oncology · doi:10.3747/co.27.6547 · Cited by 36
Metadata
- Authors
- Berman, T. A., & Schiller, J. T.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2017-03-27
- Volume
- 123
- Issue
- 12
- Pages
- 2219-2229
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2599642236
- Cited by
- 395
- References
- 68
- FWCI
- 21.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.